Insulet Corporation (GOV F) stock market data APIs
€275.4179
-11.7(-4.2%)
as of October 17, 2025
Try our APIs with
free plan!
Insulet Corporation Financial Data Overview
Price chart is built with
Anychart
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company offers Omnipod platform products comprising Omnipod 5 automated insulin delivery system, which includes a proprietary AID algorithm embedded in the pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless Bluetooth communication; and Omnipod DASH insulin management system that features a Bluetooth enabled pod that is controlled by a smartphone-like personal diabetes manager with a color touch screen user interface. It also provides pods for Amgen for use in the Neulasta Onpro kit, which is a delivery system to help reduce the risk of infection after intense chemotherapy. The company sells its products to end-users through the pharmacy channel; and independent distributors. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.
Prev. Close
275.4179
Open
263.7139
High
276.3621
Low
263.7139
52 wk Range
205.1-299.9
Market Cap
19 359 M
P/E Ratio
97.2954
Shares Outstanding
70 393 K
Revenue
2 360 M
EPS
-0.37
Beta
1.399
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Insulet Corporation data using free add-ons & libraries
Get Insulet Corporation Fundamental Data
Insulet Corporation Fundamental data includes:
- Net Revenue: 2 360 M
- EBITDA: 481 M
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2021-08-05
- EPS/Forecast: 0.13
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Insulet Corporation News
New
TransMedics Group Stock Earns Relative Strength Rating Upgrade
A Relative Strength Rating upgrade for TransMedics Group shows improving technical performance. Will it continue? Continue Reading View Comments
Insulet (PODD) Valuation: Is There More Room to Run After 22% YTD Gain?
Insulet (PODD) shares are catching attention with a recent daily dip of 1.8%, despite gaining 22% for the year. Investors might be weighing the broader trends in the medical device space as they consi...
Insulet to Host Investor Day on November 20, 2025
ACTON, Mass., October 10, 2025--(BUSINESS WIRE)--Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products...
Truist Securities Reiterates Buy Rating on Insulet (PODD) Stock
Insulet Corporation (NASDAQ:PODD) is one of the Best Long Term Growth Stocks to Buy Now.On September 17, Truist Securities analyst Richard Newitter reiterated a “Buy” rating on the company’s sto...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
